The Schiff base (H2fsal-ohyba) derived from 3-formylsalicylic acid and o-hydroxybenzylamine has been covalently bonded to chloromethylated polystyrene cross-linked with 5% divinylbenzene (abbreviated as PS-H(2)fsal-ohyba, I). Treatment of [VO(acac)2] with PS-H2fsal-ohyba in dimethylformamide (DMF) gave the oxovanadium(iv) complex PS-[VO(fsal-ohyba).DMF] (1). Complex 1 can be oxidized into the dioxovanadium(v) species, PS-K[VO2(fsal-ohyba)] (2) on aerial oxidation in the presence of KOH or into the oxoperoxo species, PS-K[VO(O2)(fsal-ohyba)] (3) in the presence of H2O2 and KOH in DMF suspension. Similarly, PS-[MoO(2)(fsal-ohyba).DMF] (4) has been isolated by the reaction of [MoO2(acac)2] with PS-H2fsal-ohyba. All these complexes have been characterised by various techniques. These complexes catalyse the oxidation of styrene, ethylbenzene and phenol efficiently. Styrene gives five reaction products namely styrene oxide, benzaldehyde, 1-phenylethane-1,2-diol, benzoic acid and phenylacetaldehyde, while ethylbenzene gives benzaldehyde, phenyl acetic acid, styrene and 1-phenylethane-1,2-diol. The oxidation products of phenol are catechol and p-hydroquinone. These catalysts are also able to catalyse the oxidative bromination of salicylaldehyde to 5-bromosalicylaldehyde with ca. 80% selectively in the presence of aqueous 30% H2O2/KBr, a reaction similar to that exhibited by vanadate-dependent haloperoxidases. Their corresponding neat complexes have also been prepared and their catalytic activities have been compared.
No takes yet. Share an insight, caveat, or question.
Maurya et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: